TCS shares rise 2% on bagging 5-year deal from NHS Supply Chain to modernise IT, deploy cloud and AI solutions

The stock was trading 1.72% higher at ₹3,140.30 per equity share, at around 11:18 am.

The stock has gained about 0.3% over the past five days and nearly 4% over the month. It has declined over 11% in the last six months. On a year-to-date basis, it has fallen approximatey 24%.

While the scrip touched a 52-week high of ₹4,494.90 on December 13, 2024, it reached a year’s low of ₹2,866.60 per equity share on October 1, 2025.

Under the partnership, TCS will deploy a host of cloud and AI-enabled solutions to modernise NHS Supply Chain’s IT systems and enhance overall operational efficiency, it said in a regulatory filing on Tuesday.

The IT firm will replace the NHS's legacy systems with a modern supply chain enterprise resource planning (ERP) solution for “faster time-to-market, seamless scalability, and enhanced customer experience.”

The Mumbai-headquartered company will also transform its legacy operations into a product and platform-based IT operating model to meet the needs of the healthcare providers' system, it added.

Commenting on the development, Matthew Wynn, Executive Director, Data and Technology, NHS Supply Chain, said: “Our partnership with TCS will play a pivotal role in the NHS Supply Chain Modernisation Programme. Working alongside our teams, TCS will help modernise our legacy systems into a more streamlined, cloud-based environment.”

NHS Supply Chain is a part of the NHS family, and its role is to source, deliver, and supply healthcare products, services, and food for NHS trusts and healthcare organisations across England and Wales.

“This shift will strengthen our resilience, improve user experience, and enable us to respond faster to changing business and customer needs. Ultimately, it will enhance our operational efficiency and service delivery as we work towards our commitment to unlock over £1 billion in recurrent value by 2030,” Wynn said.

TCS has a total market capitalisation of ₹11.31 lakh crore, as of November 19, 2025, according to data on the NSE.